SCHEMBL19794341

SCHEMBL19794341

Cc1cccc(-c2cnc(-c3ccc(Cl)cc3)cc2C)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.45
MEN1 O00255 2/20 0.45
HTT P42858 1/20 0.45
LDHA P00338 1/20 0.43
ADORA1 P30542 2/20 0.43
SCN2A Q99250 1/20 0.41
SCN10A Q9Y5Y9 1/20 0.41
ENPP3 O14638 2/20 0.40
CNR1 P21554 2/20 0.39
TGFBR1 P36897 2/20 0.39
IDO1 P14902 1/20 0.39
METAP2 P50579 1/20 0.39
RAB9A P51151 2/20 0.39
MAPK1 P28482 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
KDM1A O60341 2/20 0.38
KMO O15229 1/20 0.38
MAOA P21397 1/20 0.38
ADORA2A P29274 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12285709 0.88 ADORA1 (0.49) KMT2ALDHAADORA1TGFBR1IDO1
SCHEMBL18015350 0.87 LDHA (0.49) KMT2AMEN1LDHAADORA1CNR1
SCHEMBL18015342 0.86 LDHA (0.54) KMT2AMEN1LDHAADORA1RAB9A
SCHEMBL18015348 0.86 PIM1 (0.44) KMT2AMEN1HTTLDHAIDO1
SCHEMBL18015339 0.82 ADORA2A (0.44) KMT2AMEN1HTTADORA1SCN2A
SCHEMBL18508269 0.79 ADORA1 (0.44) KMT2AMEN1LDHAADORA1TGFBR1
SCHEMBL18015344 0.79 RAB9A (0.45) KMT2AMEN1LDHAIDO1RAB9A
SCHEMBL21202790 0.78 LDHA (0.51) KMT2AMEN1LDHAADORA1ENPP3
SCHEMBL20007323 0.77 LDHA (0.45) KMT2AMEN1LDHAADORA1ENPP3
SCHEMBL19794342 0.77 LIPG (0.47) LDHAADORA1ENPP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11024815-B2 Metal complexes MERCK PATENT GMBH (DE) 2021-06-01 US disclosed
US-20180026209-A1 Metal Complexes MERCK PATENT GMBH (DE) 2018-01-25 US disclosed
US-20180026209-A1 Metal Complexes MERCK PATENT GMBH (DE) 2018-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11024815-B2 Metal complexes EXOC4, EXOC3, TIMCC KMT2A 3131/4885MEN1 2821/4885HTT 1728/4885
US-20180026209-A1 Metal Complexes AP3M1, AP2M1, SOD1 KMT2A 3024/4885MEN1 1212/4885HTT 1827/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.